Antibe Therapeutics Analysis
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-12-31
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2023-09-30
|
-0.12
|
-0.10
|
0.02
|
16.67%
|
|
2023-06-30
|
-0.09
|
-0.11
|
-0.02
|
-22.22%
|
|
2023-03-31
|
-0.11
|
-0.06
|
0.05
|
45.45%
|
|
2022-12-31
|
-0.12
|
-0.08
|
0.04
|
33.33%
|
|
2022-09-30
|
-0.12
|
-0.12
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.12
|
-0.10
|
0.02
|
16.67%
|
|
2022-03-31
|
-0.16
|
-0.11
|
0.05
|
31.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-0.29
|
|
2023-03-31
|
-0.36
|
|
2022-03-31
|
-0.50
|
|
2021-03-31
|
-0.71
|
|
2020-03-31
|
-0.62
|
|
2019-03-31
|
-0.33
|
|
2018-03-31
|
-0.37
|
|
2017-03-31
|
-0.46
|
|
2016-03-31
|
-0.44
|
|
2015-03-31
|
-0.27
|
|
2014-03-31
|
-1.20
|
|
2013-03-31
|
-0.58
|
|
2012-03-31
|
-0.48
|